EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical study design and modeling approaches to study secretion of drugs in human milk

Prerna Dodeja, Nupur Chaphekar, Taylor Laffey, Hamdan Albukhaytan, Steve Caritis, Imam Shaik, Raman Venkataramanan

Frontiers in Pediatrics · 17.06.2026 · 14

DOI: 10.3389/fped.2026.1843294 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 17.06.2026. Verfasst von Prerna Dodeja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA, United States. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breastfeeding has a multitude of benefits for both the lactating mother and her infant. However, lactating women often require medications for chronic and acute medical conditions, which may pose a significant risk due to drug transfer to infants via breastfeeding. Although most drugs may pass into human milk via passive diffusion, this should rarely be a reason to completely stop breastfeeding. Drug secretion into human milk is an area of research with a paucity of data. Performing clinical studies in lactating women is essential for understanding infant drug safety. However, it is practically challenging to enroll lactating women in these studies solely for the purpose of quantifying drug transfer into human milk. In the absence of clinical studies, non-clinical models—including in vitro , in vivo (animal studies), and in silico (predictive modeling tools)—can provide valuable insight into drug secretion into human milk. The objectives of this review are to summarize existing pharmacokinetic metrics to quantify drug transfer to human milk and elaborate upon clinical study designs in lactation. Furthermore, we aim to explore the utility of non-clinical models to quantify drug transfer into human milk, given the absence of clinical data. Finally, we discuss in silico models, including empirical equations used to derive milk-to-plasma ratios, as well as pharmacokinetic models to predict and analyze drug concentration-time profiles during lactation.

Schlagwörter

Stichwörter der Autor:innen

clinical studyhuman milklactationnon-clinical modelspharmacokinetic modelingphysiologically based pharmacokinetic modelingpopulation pharmacokinetic modeling

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA, United States.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, Magee Women's Hospital, Pittsburgh, PA, United States.
  • Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.
  • Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Zitieren

APA

Dodeja, P., Chaphekar, N., Laffey, T., Albukhaytan, H., Caritis, S., Shaik, I., & Venkataramanan, R. (2026). Clinical study design and modeling approaches to study secretion of drugs in human milk. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1843294

Vancouver

Dodeja P, Chaphekar N, Laffey T, Albukhaytan H, Caritis S, Shaik I, et al. Clinical study design and modeling approaches to study secretion of drugs in human milk. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1843294

BibTeX
@article{Dodeja2026,
  author = {Dodeja, Prerna and Chaphekar, Nupur and Laffey, Taylor and Albukhaytan, Hamdan and Caritis, Steve and Shaik, Imam and Venkataramanan, Raman},
  title = {Clinical study design and modeling approaches to study secretion of drugs in human milk},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1843294}
}
Kostenlos starten →